Clinical Trials and Research

Join this 30-minute Cardio Town Hall, moderated and led by Dr. Mazen Hanna and Dr. Mathew Maurer for an expert discussion on contemporary ATTR-CM clinical research…

Cardiac involvement is the principal determinant of prognosis in light-chain (AL) amyloidosis. B-type natriuretic peptide (BNP) and N-terminal pro-B-type…

Significant gaps remain in diagnosing hereditary transthyretin amyloidosis (hATTR) within the Black population, a new study in the Journal of Community Genetics…